74777
黄芪甲苷IV
>98.0%
登录查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C41H68O14
化学文摘社编号:
分子量:
784.97
MDL编号:
UNSPSC代码:
41106200
PubChem化学物质编号:
NACRES:
NA.85
质量水平
方案
≥98.0% (TLC)
>98.0%
表单
powder
mp
295-296 °C (lit.)
SMILES字符串
CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O
InChI
1S/C41H68O14/c1-35(2)24(54-33-29(48)26(45)20(44)17-51-33)9-11-41-18-40(41)13-12-37(5)31(39(7)10-8-25(55-39)36(3,4)50)19(43)15-38(37,6)23(40)14-21(32(35)41)52-34-30(49)28(47)27(46)22(16-42)53-34/h19-34,42-50H,8-18H2,1-7H3/t19-,20+,21-,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34+,37+,38-,39+,40-,41+/m0/s1
InChI key
QMNWISYXSJWHRY-YLNUDOOFSA-N
正在寻找类似产品? 访问 产品对比指南
生化/生理作用
抗炎。
其他说明
黄芪的化学成分
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Xiaoyan Gu et al.
Molecular medicine reports, 6(1), 115-120 (2012-04-17)
Astragaloside IV (AS-IV) has been noted for its reduction of eosinophilic airway inflammation in a murine model of chronic asthma. To gain a better understanding of the mechanisms involved in this anti-inflammatory phenomenon, the effect of AS-IV on human blood
Rui-Na Zhou et al.
Drug metabolism and pharmacokinetics, 27(6), 586-597 (2012-06-08)
Astragaloside IV (AIV) is the most abundant saponin and a marker compound in Astragali Radix, a Chinese herb notable for its anti-aging and immune-enhancing effects. The present study investigated the role of intestinal bacterial conversion in the in vivo fate
Li-Hua Peng et al.
Biological & pharmaceutical bulletin, 35(6), 881-888 (2012-06-13)
Topical delivery of therapeutic agents at the time of injury to accelerate skin repair and prevent the formation of scars during the wound healing process has received increasing attention and represents a novel regenerative and prophylactic strategy for wound treatment.
Chemical & Pharmaceutical Bulletin, 31, 709-709 (1983)
Dingkun Gui et al.
Cytokine, 61(3), 970-977 (2013-02-26)
Accumulating evidence suggests that inflammatory processes are involved in the development of diabetic nephropathy (DN). However, there are no effective interventions for inflammation in the diabetic kidneys. Here, we tested the hypothesis that Astragaloside IV(AS-IV), a novel saponin purified from
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持